Research
Mixed
Specific DNA methylation alterations in blood (e.g., ABCG1, TXNIP, SLC30A8) can predict the onset of Type 2 Diabetes (T2D) prior to clinical diagnosis, offering a window for early detection.
If you have risk factors for Type 2 Diabetes (high BMI, family history), ask your doctor about emerging epigenetic biomarkers if available. While not yet standard of care, these tests may detect metabolic risk earlier than blood sugar tests, allowing for earlier lifestyle interventions.
GoodSupportsHIGH confidence
One impressive example of such alterations is the occurrence of dynamic DNA methylation changes in Peripheral Blood Mononuclear Cells (PBMCs) ~80–90 days prior to elevated glucose levels.
Why this rating
Supported by multiple EWAS studies and prospective cohorts, though replication varies.
Source
DNA Methylation Biomarkers in Aging and Age-Related Diseases
Yasmeen Salameh et al. · Frontiers in Genetics · 2020
DOI 10.3389/fgene.2020.00171
narrative_reviewCited 334×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- DNA methylation-based epigenetic clocks serve as accurate biomarkers for predicting biological age, disease risk, and mortality, often outperforming traditional chronological age metrics.Good
- Epigenetic age acceleration, measured by DNA methylation clocks, is associated with increased risk of Cardiovascular Disease (CVD) and mortality.Good
- DNA methylation biomarkers in blood (e.g., ANK1, DAPK1, BDNF) are associated with Alzheimer's Disease (AD) risk and neuropathology, potentially enabling earlier detection.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →